Found: 15
Select item for more details and to access through your institution.
Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Reversing Hepatic Fibrosis in 3D Liver Spheroids.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1849, doi. 10.3390/biomedicines12081849
- By:
- Publication type:
- Article
Extracellular Vesicles Derived from Human Liver Stem Cells Attenuate Chronic Kidney Disease Development in an In Vivo Experimental Model of Renal Ischemia and Reperfusion Injury.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1485, doi. 10.3390/ijms23031485
- By:
- Publication type:
- Article
A First Phenotypic and Functional Characterization of Placental Extracellular Vesicles from Women with Multiple Sclerosis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 6, p. 2875, doi. 10.3390/ijms22062875
- By:
- Publication type:
- Article
Extracellular Vesicles: A Therapeutic Option for Liver Fibrosis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4255, doi. 10.3390/ijms21124255
- By:
- Publication type:
- Article
Anti-fibrotic and anti-inflammatory effect of mesenchymal stromal cell-derived extracellular vesicles in chronic kidney disease.
- Published in:
- Biocell, 2023, v. 47, n. 7, p. 1499, doi. 10.32604/biocell.2023.028121
- By:
- Publication type:
- Article
Extracellular vesicles from human plasma for biomarkers discovery: Impact of anticoagulants and isolation techniques.
- Published in:
- PLoS ONE, 2023, v. 18, n. 5, p. 1, doi. 10.1371/journal.pone.0285440
- By:
- Publication type:
- Article
Extracellular Vesicles Derived from Human Liver Stem Cells Counteract Chronic Kidney Disease Development and Cardiac Dysfunction in Remnant Kidney Murine Model: The Possible Involvement of Proteases.
- Published in:
- Biomedicines, 2024, v. 13, n. 7, p. 1517, doi. 10.3390/biomedicines12071517
- By:
- Publication type:
- Article
Concise Review: Different Mesenchymal Stromal/Stem Cell Populations Reside in the Adult Kidney.
- Published in:
- Stem Cells Translational Medicine, 2014, v. 3, n. 12, p. 1451, doi. 10.5966/sctm.2014-0142
- By:
- Publication type:
- Article
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8- gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.844250
- By:
- Publication type:
- Article
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas—A Preclinical and Translational Study.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6295, doi. 10.3390/cancers13246295
- By:
- Publication type:
- Article
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1519, doi. 10.3390/cancers12061519
- By:
- Publication type:
- Article
Salivary Extracellular Vesicle-Associated exRNA as Cancer Biomarker.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 891, doi. 10.3390/cancers11070891
- By:
- Publication type:
- Article
Mesenchymal Stromal Cells Epithelial Transition Induced by Renal Tubular Cells-Derived Extracellular Vesicles.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0159163
- By:
- Publication type:
- Article
TFEB controls vascular development by regulating the proliferation of endothelial cells.
- Published in:
- EMBO Journal, 2019, v. 38, n. 3, p. 1, doi. 10.15252/embj.201798250
- By:
- Publication type:
- Article
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0652-5
- By:
- Publication type:
- Article